Efalizumab

Details

Files

Generic Name:

Efalizumab

Project Status:

Complete

Therapeutic Area:

Psoriasis, moderate to severe chronic plaque

Manufacturer:

Serono Canada Inc.

Brand Name:

Raptiva

Project Line:

Reimbursement Review

Project Number:

SF0102-000

Submission Type:

Request For Advice

Indications:

Psoriasis, moderate to severe chronic plaque

Recommendation Type:

N/A

Files

Submission Status Report View PDF

Last Updated : June 19, 2007